NVO
USDNovo Nordisk A/S Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$46.220
Haut
$46.360
Bas
$45.570
Volume
37.86M
Fondamentaux de l'Entreprise
Capitalisation Boursière
210.1B
Industrie
Drug Manufacturers - General
Pays
Denmark
Statistiques de Trading
Volume Moyen
15.16M
Bourse
NYQ
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.
November trading, Berkshire's cash hoard, Big Tech's ad revenue and more in Morning Squawk
Here are five key things investors need to know to start the trading day.
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound
Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.